Fuhai Li, PhD

Washington University in St. Louis (WU)

My recent research has focused on the integration and interpretation of diverse and heterogeneous pharmacogenomics data using statistical and machine learning approaches for i) understanding driver genetics/functional (mechanism), ii) discovering novel combinatory therapies to overcome intrinsic/acquired drug resistance (with reduced toxicity and synergy effects), and iii) uncovering and perturbing the tumor-stroma interaction to understand the roles of tumor micro-environment/niche in disease development.